-
Lilly Begins Study for Second Potential COVID-19 Antibody Treatment
americanpharmaceuticalreview
June 17, 2020
Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19.
-
Modelling the human body: a game changer for drug testing?
pharmaceutical-technology
June 17, 2020
Scientists at the Wake Forest Institute for Regenerative Medicine say they have developed the world's most sophisticated laboratory model of the human body.
-
Saiba AG and AGC Biologics Enter COVID-19 Vaccine Partnership
contractpharma
June 17, 2020
AGC will manufacture SARS-CoV-2 vaccine for the Swiss biotech.
-
Vyripharm and Regis Sign Off on a Master Drug Program Agreement
contractpharma
June 17, 2020
For expediting cGMP manufacture of antiviral agents for diagnostic evaluation of COVID-19.
-
US FDA warns against co-administration of remdesivir and chloroquine or HCQ
expresspharma
June 17, 2020
The drug regulator informs that this may reduce the antiviral activity of remdesivir and lessen the effectiveness of COVID-19 treatment.
-
Scientists discover new super-potent human antibodies that can protect against COVID-19
expresspharma
June 17, 2020
These antibodies may also be used to provide temporary, vaccine-like protection against SARS-CoV-2 infection for healthcare workers, elderly people, and others who respond poorly to traditional vaccines.
-
Curcumin could benefit in COVID-19 treatment: Researchers
expresspharma
June 17, 2020
In these uncertain days of the highly contagious coronavirus, the absence of pharmaceutical intervention in the form of drugs or vaccines has pushed scientists to look for clues among safe herbal extract ingredients.
-
Dexamethasone, low cost steroid drug can reduce COVID-19 mortality
expresspharma
June 17, 2020
Hailing it is a ‘major breakthrough’, researchers claim that this medicine reduced death rates by around a third among the most severely ill COVID-19 patients admitted to hospital.
-
Local authorities in England get funding for test and trace
pharmatimes
June 16, 2020
The government has confirmed a funding stream of £300 million for local authorities in England to help facilitate COVID-19 action plans including the new track and trace service in their areas.
-
Researchers to test potential COVID-19 treatment in UK
pharmatimes
June 16, 2020
Researchers are gearing up to evaluate whether a new drug can prevent lung damage and blood clots in people with COVID-19 in hospitals in the UK.